PAPER Kolykhanov IV, Fedorova Ia, Gavrilova SI
SEARCH RESULTS
331397 RESULTS
PAPER Vasenina EE
[Cholinesterase inhibitors in the treatment of mixed dementia].
Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(7 Pt 2):98-103. PubMed: 23994939PAPER Mendez MF, Sabodash V
Clinical Amyloid Imaging in Logopenic Progressive Aphasia.
Alzheimer Dis Assoc Disord. 2013 Aug 29; PubMed: 23995816PAPER Tartaglia MC, Hu B, Mehta K, Neuhaus J, Yaffe K, Miller BL, Boxer A
Demographic and Neuropsychiatric Factors Associated With Off-label Medication Use in Frontotemporal Dementia and Alzheimer's Disease.
Alzheimer Dis Assoc Disord. 2013 Aug 29; PubMed: 23995817PAPER Nishtala A, Preis SR, Beiser A, Devine S, Hankee L, Seshadri S, Wolf PA, Au R
Midlife Cardiovascular Risk Impacts Executive Function: Framingham Offspring Study.
Alzheimer Dis Assoc Disord. 2013 Aug 29; PubMed: 23995818PAPER Sharma AK, Pavlova ST, Kim J, Mirica LM
The effect of Cu(2+) and Zn(2+) on the Aβ42 peptide aggregation and cellular toxicity.
Metallomics. 2013 Oct 23;5(11):1529-36. PubMed: 23995980PAPER Hurth K, Tarawneh R, Ghoshal N, Benzinger TL, Clifford DB, Geschwind M, Morris JC, Galvin JE, Schmidt RE, Cairns NJ
Whipple's Disease Masquerades as Dementia With Lewy Bodies.
Alzheimer Dis Assoc Disord. 2013 Aug 29; PubMed: 23995819PAPER Basu R
Willingness-to-pay to prevent Alzheimer's disease: a contingent valuation approach.
Int J Health Care Finance Econ. 2013 Dec;13(3-4):233-45. PubMed: 23996130PAPER Chen Y, Liang Z, Tian Z, Blanchard J, Dai CL, Chalbot S, Iqbal K, Liu F, Gong CX
Intracerebroventricular Streptozotocin Exacerbates Alzheimer-Like Changes of 3xTg-AD Mice.
Mol Neurobiol. 2013 Aug 31; PubMed: 23996345PAPER Köhler S, Hamel R, Sistermans N, Koene T, Pijnenburg YA, van der Flier WM, Scheltens P, Visser PJ, Aalten P, Verhey FR, Ramakers I
Progression to dementia in memory clinic patients without dementia: A latent profile analysis.
Neurology. 2013 Oct 8;81(15):1342-9. PubMed: 23997152PAPER Hita-Yañez E, Atienza M, Cantero JL
Polysomnographic and subjective sleep markers of mild cognitive impairment.
Sleep. 2013 Sep;36(9):1327-34. PubMed: 23997365PAPER Modirrousta M, Price BH, Dickerson BC
Neuropsychiatric symptoms in primary progressive aphasia: phenomenology, pathophysiology, and approach to assessment and treatment.
Neurodegener Dis Manag. 2013 Apr 1;3(2):133-146. PubMed: 23997827PAPER D'Adamio L, Castillo PE
Presenilin-ryanodine receptor connection.
Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):14825-6. PubMed: 23995445PAPER de Jong LW, Forsberg LE, Vidal JS, Sigurdsson S, Zijdenbos AP, Garcia M, Eiriksdottir G, Gudnason V, van Buchem MA, Launer LJ
Different susceptibility of medial temporal lobe and basal ganglia atrophy rates to vascular risk factors.
Neurobiol Aging. 2014 Jan;35(1):72-8. PubMed: 23992618Ubiquitin Research and Drug Discovery Conference, 2014
CONFERENCE 2014-02-20 00:00:00-2014-02-21 00:00:00 San Diego, CA, U.S.A. 20 – 21 February 2014 This premier conference will host an exciting group of professionals from the academic, biotech, pharmaceutical, and business communities, and will focus on drug discovery aspects within the ubiquitin
Current Filters
No filters selected